TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 565 participants.
Also called NCT07798726
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 565 participants
- Sponsor
- Registry
-
NCT07798726
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07798726. Non-randomized; no masking; primary purpose treatment. Start 2026-10-21 (actual); primary completion 2031-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System
- Acronym
- CROWN-MV
- Condition
- Mitral Valve Disease
- Condition
- Mitral Annulus Calcification
- Condition
- Mitral Regurgitation
- Condition
- Mitral Stenosis
- Condition
- Mitral Valve (MV) Regurgitation
- Condition
- Mitral Valve Replacement
- Condition
- Transcatheter Valve Replacement
- Condition
- Mitral Valve Insufficiency
- Condition
- Heart Valve Disease
- Intervention (Device)
- Cephea Mitral Valve System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct07798726- Content hash
bdfcfde3b451f95d17a310cd050a74a21fb80fa31057b432578c41667046bda0